A randomized cross-over study comparing pharmacodynamic and metabolic variables of a new combiphasic and a well-established triphasic oral contraceptive

References

• Dieben TOM, van Beek A, Coelingh Bennink HJT. Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Arzneimittelforschung 1991; 41: 996–8
   PubMed Web of Science ®Google Scholar
• Dieben TOM, op ten Berg MT, Coelingh Bennink HJT. Cycle control and side effects of a new combiphasic oral contraceptive regimen. Arzneimittelforschung 1994; 44: 877–9
   PubMed Web of Science ®Google Scholar
• Oddens BJ, Arnolds HT, van Maris MGM, van Lunsen HW. The dynamics of oral contraceptive use in the Netherlands 1990–1993. Adv Contracept 1994; 10: 167–74
   PubMedGoogle Scholar
• Dieben TOM, Vromans L, Theeuwes A, Coelingh Bennink HJT. The effects of CTR-24, a biphasic oral contraceptive combination, compared to Diane-35 in women with acne. Contraception 1994; 50: 373–82
   PubMed Web of Science ®Google Scholar
• Falsetti L. Acne treatment with a new estroprogestimc biphasic combination containing desogestrel. Acta Eur Fertil 1991; 22: 283–6
   PubMedGoogle Scholar
• Volpe A, Silferi M, Mauri A, et al. Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel. Eur J Obstet Gynecol Reprod Biol 1994; 53: 205–9
   PubMed Web of Science ®Google Scholar
• Hesse R, Tritschler W, Castelfranchi G, Bablok W. Antithrombin III: Referenzwerte mit einem chromogenen Substrat (Cromozym TH). Blut 1981; 42: 227–34
   PubMedGoogle Scholar
• Barthelmai W, Czok R. Enzymatische Bestimmung der Glucose in Blut, Liquor und Harn. Klin Wochenschr 1962; 40: 585–9
   PubMedGoogle Scholar
• Heding LG. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972; 8: 260–6
   PubMed Web of Science ®Google Scholar
• Kloosterboer HJ, Bruining GJ, Lund L, . Serum glycosylated proteins as a measure of carbohydrate metabolism in OC users. Trends in Oral Contraception. Lancaster, R Harrison, J Bonnar, W Thompson, et al, 1983; 9–15, MTP Press
   Google Scholar
• Schosinski KH, Lehman HP, Beller MF. Measurement of ceruloplasmin from its oxidase activity in serum by use of O-dianisidine dihydrochloride. Clin Chem 1974; 20: 1556–63
   PubMed Web of Science ®Google Scholar
• Schiller HS, Petra PH. A filter assay for the corticosteroid binding globulin of human serum. J Steroid Biochem 1976; 7: 55–9
   PubMedGoogle Scholar
• Bergink EW, Holma P, Pyörälä T. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding. Scand J Clin Lab Invest 1981; 41: 663–8
   PubMed Web of Science ®Google Scholar
• Trinder P. Simple turbidimetric method for the determination of serum cholesterol. Ann Clin Biochem 1969; 6: 165–6
   Google Scholar
• Eggstein H, Kreutz FH. Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe. Klin Wochenschr 1966; 44: 262–7
   PubMedGoogle Scholar
• Takayama M, Itoh S, Nagasaki T, Tamimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Client Acta 1977; 79: 93–8
   PubMed Web of Science ®Google Scholar
• Terpstra AHM, Woodward CJH, Sanchez-Muniz FJ. Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum. Anal Biochem 1981; 111: 149–57
   PubMed Web of Science ®Google Scholar
• Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1978; 11: 583–95
   Google Scholar
• Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three methods. Clin Chem 1977; 23: 882–4
   PubMed Web of Science ®Google Scholar
• Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45–52
   PubMed Web of Science ®Google Scholar
• Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol 1979; 8: 7–20
   PubMed Web of Science ®Google Scholar
• Guillebaud J. The forgotten pill—and the paramount importance of the pill-free week. Br J Fam Plann 1987; 12(Suppl 4)35–43
   Google Scholar
• Kuhl H, Jung-Hoffmann C, Weber J, Boehm BO. The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters. Contraception 1993; 47: 55–68
   PubMed Web of Science ®Google Scholar
• Spellacy WN, Buhi WC, Birk SA. The effect of estrogens on carbohydrate metabolism: glucose, insulin, and growth hormone studies in one hundred and seventy women ingesting Premarin, mestranol, and ethinyl estradiol for six months. Am J Obstet Gynecol 1972; 114: 378–92
   PubMed Web of Science ®Google Scholar
• Spellacy WN, Buhi WC, Birk SA. The effects of two years of mestranol treatment on carbohydrate metabolism. Metabolism 1982; 31: 1006–8
   PubMed Web of Science ®Google Scholar
• Godsland IF, Walton C, Felton C, et al. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 1991; 74: 64–70
   Web of Science ®Google Scholar
• Gaspard U, Lefebre PJ. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease. Am J Obstet Gynecol 1990; 163: 334–43
   PubMed Web of Science ®Google Scholar
• Drien TG. Human corticosteroid binding globulin. Clin Endocrinol 1981; 14: 193–212
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Eisalo A, Heino A, et al. Investigations on the effects of an oral contraceptive and its components on liver function, serum proteins, copper, ceruloplasmin and gamma-glutamyl peptidase in postmenopausal women. Scand J Gastroenterol 1968; 3: 273–84
   PubMed Web of Science ®Google Scholar
• Jung-Hoffmann C, Storch A, Kuhl H. Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel. Horm Res 1992; 38: 184–9
   PubMed Web of Science ®Google Scholar
• Cullberg G, Dovré PA, Lindstedt G, Steffensen K. On the use of plasma proteins as indicators of the metabolic effects of combined oral contraceptives. Acta Obstet Gyuecol Scand. 1982; 47–54, (Suppl 111): –
   Google Scholar
• Liukko P, Erkkola R, Bergink EW. Progestagen-dependent effect on some plasma proteins during oral contraception. Gynecol Obstet Invest 1988; 25: 118–22
   PubMed Web of Science ®Google Scholar
• Lobl TJ. Androgen transport proteins:physical properties, hormonal regulation, and possible mechanism of TeBG and ABP action. Arch Androl 1981; 7: 133–51
   PubMed Web of Science ®Google Scholar
• Kloosterboer HJ, Vonk Noordegraaf CA, Turpijn EW. Selectivity in progesterone-and androgen-receptor binding of progestogens used in oral contraceptives. Contraception 1988; 38: 325–32
   PubMed Web of Science ®Google Scholar
• Mammen EF. Oral contraception and blood coagulation: a critical review. Am J Obstet Gynecol 1982; 142: 781–90
   PubMed Web of Science ®Google Scholar
• Kuhl H, März W, Jung-Hoffmann C, et al. Effect on lipid metabolism of a biphasic desogestrel-containing oral contraceptive: divergent changes in apolipoprotein B and E and transitory decrease in Lp(a) levels. Contraception 1993; 47: 69–83
   PubMed Web of Science ®Google Scholar
• Jacobs DR, Mebane IL, Bangdiwala SI, et al. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990; 131: 32–47
   PubMed Web of Science ®Google Scholar
• Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987; 114: 413–19
   PubMed Web of Science ®Google Scholar
• Livshits G, Weisbort J, Meshulam N, Brunner D. Multivariate analysis of the twenty-year follow-up of the Donol-Tel Aviv Prospective Coronary Artery Disease Study and the usefulness of high density lipoprotein cholesterol percentage. Am J Cardiol 1989; 63: 676–81
   PubMed Web of Science ®Google Scholar
• Manninen V, Elo MO, Frick MH, et al. Lipoprotein alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. J Am Med Assoc 1988; 260: 641–51
   PubMed Web of Science ®Google Scholar
• Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive hpid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289–98
   PubMed Web of Science ®Google Scholar
• Blankenhorn DH, Johnson RL, Nessim SA, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. J Am Med Assoc 1987; 257: 3233–40
   PubMed Web of Science ®Google Scholar
• Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986; 112: 432–7
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. Triglyceride, high-density lipoprotein, and coronary heart disease. J Am Med Assoc, 269: 505–10, 1993
   Web of Science ®Google Scholar
• Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non-contraceptive estrogen use in women: results from the Lipid Research Clinics' Program Follow-Up Study. Circulation 1987; 75: 1002–9
   Google Scholar
• Lewis MA, Spitzer WO, Heinemann LA, et al. on behalf of the Transnational Research Group on Oral Contraceptives and the Health of Young Women. Br Med J 1996; 312: 88–90
   PubMed Web of Science ®Google Scholar
• Jick H, Jick SS, Wald Myers M, Vasilakis C. Risk of acute myocardial infarction and low-dose combined oral contraceptives. Lancet 1996; 347: 627–8
   PubMed Web of Science ®Google Scholar
• Consensus Development meeting. Metabolic aspects of oral contraceptives of relevance for cardiovascular diseases. Am J Obstet Gynecol, 162: 1335–7, 1990
   Web of Science ®Google Scholar